Metabolomic‐based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts-Reference-Cited by-同舟云学术

Metabolomic‐based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts

Published:2018-05-04 Issue:7 Volume:2 Page:807-820
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatology Communications

Author:

Mayo Rebeca¹,Crespo Javier²,Martínez‐Arranz Ibon¹,Banales Jesus M³,Arias Mayte²,Mincholé Itziar¹,Aller de la Fuente Rocío⁴,Jimenez‐Agüero Raúl³,Alonso Cristina¹,de Luis Daniel A.⁵,Vitek Libor⁶,Stritesky Jan⁶,Caballería Joan⁷,Romero‐Gómez Manuel⁸,Martín‐Duce Antonio⁹,Mugüerza Huguet Jose Maria¹⁰,Busteros‐Moraza José Ignacio¹¹,Idowu Michael O.¹²,Castro Azucena¹,Martínez‐Chantar M. Luz¹³,Ortiz Pablo¹,Bruha Radan⁶,Lu Shelly C.¹⁴,Bedossa Pierre¹⁵,Noureddin Mazen¹⁴,Sanyal Arun J.¹⁶,Mato José M.¹³

Affiliation:

1. OWL MetabolomicsBizkaia Technology ParkDerio Spain

2. Department of Digestive DiseaseMarqués de Valdecilla University Hospital, Cantabaria UniversityResearch Institute Marqués de Valdecilla (IDIVAL) Santander Spain

3. Department of Liver and Gastrointestinal Diseases, Biodonostia Research InstituteDonostia University Hospital, University of the Basque Country (UPV‐EHU)CIBERehd, IKERBASQUE Donostia Spain

4. Department of Digestive Disease, Clinic University HospitalUniversity of ValladolidValladolid Spain

5. Center of Investigation of Endocrinology and Clinical Nutrition, Medicine School and Department of Endocrinology and Nutrition, Clinic University HospitalUniversity of ValladolidValladolid Spain

6. Faculty General Hospital and the First Faculty of MedicineCharles UniversityPrague Czech Republic

7. Liver Unit, Hospital Clinic, CIBERehdIDIBAPSBarcelona Spain

8. Unit for the Clinical Management of Digestive Diseases and CIBERehdValme University HospitalSeville Spain

9. Faculty of Medicine and Health ScienceUniversity Hospital Príncipe de Asturias, Alcalá UniversityMadrid Spain

10. Surgery DepartmentUniversity Hospital Príncipe de Asturias, Alcalá UniversityMadrid Spain

11. Department of PathologyUniversity Hospital Príncipe de Asturias, Alcalá UniversityMadrid Spain

12. Division of Surgical Pathology, Department of PathologyVirginia Commonwealth University Medical CenterRichmond VA United States

13. CIC bioGUNE, CIBERehdBizkaia Technology ParkDerio Bizkaia Spain

14. Division of Digestive and Liver DiseasesCedars‐Sinai Medical CenterLos Angeles CA United States

15. Department of PathologyUniversity Hospitals Paris Nord Val de Seine, Beaujon, Hauts‐de‐SeineClichy France

16. Division of Gastroenterology and HepatologyVirginia Commonwealth University Medical CenterRichmond VA United States

Funder

NIH Blueprint for Neuroscience Research

CIBER

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1188

Reference49 articles.

1. NASH and HCC

2. Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection

3. Epidemiology of Non-Alcoholic Fatty Liver Disease

4. Non-alcoholic fatty liver disease pathogenesis: The present and the future

5. Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct changes in serum metabolites and lipid species in the onset and progression of NAFLD in Obese Chinese;Computational and Structural Biotechnology Journal;2024-12

2. Diagnostics and omics technologies for the detection and prediction of metabolic dysfunction-associated steatotic liver disease-related malignancies;Metabolism;2024-12

3. Noninvasive testing in the diagnosis of metabolic dysfunction-associated steatohepatitis;Metabolism and Target Organ Damage;2024-08-22

4. One‐step non‐invasive diagnosis of metabolic dysfunction‐associated steatohepatitis and fibrosis in high‐risk population;United European Gastroenterology Journal;2024-08-04

5. Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases;Journal of Hepatology;2024-08